Accretion Nutraveda Ltd
Complete IPO details, including price band, financials, subscription status, and key insights.
Participate in the Accretion Nutraveda Ltd IPO with full transparency. Review issue details, company fundamentals, and financial performance, and apply securely through Alice Blue.
IPO Snapshot
Key metrics and details at a glance.
Price Band
₹129
Per ShareLot Size
1000 Shares
Minimum Investment
₹1,29,000
Issue Size
₹24.77 Cr
Face Value
₹10
Per ShareIPO Type
Book Building - SME
Retail Quota
35.09%
QIB Quota
49.78%
NII Quota
15.13%
IPO Timeline
Important dates for your applying strategy.
Subscription Status
Live demand across investor categories.
Track real-time subscription levels:
*Real-time data subject to exchange updates
Accretion Nutraveda Ltd
Business model, operations, and market positioning.
Promoter Holding (Pre-Issue)
92.48%
Promoter Holding (Post-Issue)
55.08%
Issue Type
Book Building - SME
ISIN
INE1KVQ01019
About the Company
Accretion Nutraveda Limited, founded in 2021 in Ahmedabad, is a healthcare-focused Contract Development and Manufacturing Organization (CDMO). The company specializes in ayurvedic and nutraceutical products including tablets, capsules, oral liquids, oral powders, external preparations and oils. Its portfolio spans diverse healthcare segments such as bone and joint care, respiratory care, gynec care, digestive care, cardiac care, liver care, paediatric care, skin and hair care, urinary and UTI care, baby care products and memory and neuron care. Operating from a 10,763 sq. ft. GMP-compliant facility in Sanand, Gujarat, the company holds ISO, WHO-GMP, and Halal certifications, ensuring global quality and safety standards.
Industry Overview
Accretion Nutraveda Limited has established itself as a trusted Contract Development and Manufacturing Organization (CDMO), providing specialized services to clients across industries. The company operates in the healthcare sector with a strong focus on ayurvedic and nutraceutical products. Its wide portfolio includes ayurvedic formulations for bone and joint care, respiratory care, gynec care, digestive care, urinary tract care, skin and hair care. Additionally, it offers nutraceutical and health supplements for memory and neuron care, cardiac care, UTI care, liver care, paediatric care, and gastrointestinal care. Through diverse SKUs, the company caters to evolving healthcare and wellness needs.
Company History
Our Company was incorporated on March 16, 2021 as `Accretion Nutraveda Private Limited' which further converted on May 02, 2025 as `Accretion Nutraveda Limited', a public limited company under the Companies Act, 2013, pursuant to a certificate of incorporation dated May 02, 2025 issued by the Registrar of Companies, Central Processing Centre.
Products & Services
- Accretion Nutraveda Limited, founded in 2021 in Ahmedabad, is a healthcare-focused Contract Development and Manufacturing Organization (CDMO).
Growth Strategy
- Strengthening Sales and Marketing Network.
- Enhancing Global Presence through Direct Exports.
- Expanding and Differentiating Product Portfolio.
- Leveraging Market Relationships and Industry Engagement.
- Sustaining Competitive Advantage.
- Customer Satisfaction and Retention.
Customer Base
Wholesaler and Retailer
Financial Performance
Revenue, profit after tax and total assets across the last 3 reported financial years.
Revenue
Amount in ₹ crore
Profit After Tax (PAT)
Amount in ₹ crore
Total Assets
Amount in ₹ crore
Figures in ₹ crore, on a standalone basis, as reported for FY24 to FY26.
Objects of the Issue
How the company plans to utilize IPO proceeds.
Use of Proceeds
The funds raised through this IPO will be used for:
Initial public issue of up to 19,20,000 equity shares of face value of Rs. 10/- each of Accretion Nutraveda Limited ("Accretion" or the "company" or the "issuer") for cash at a price of Rs.129/- per equity share including a share premium of Rs.119/- per equity share (the "issue price") aggregating to Rs.24.77 crores ("the Issue"), of which 96,000 equity shares of face value of Rs. 10/- each for cash at a price of Rs.129/- per equity share including a share premium of Rs.119 /- per equity share aggregating to Rs.1.24 crores will be reserved for subscription by market maker to the issue (the "market maker reservation portion"). The issue less the market maker reservation portion i.e. net issue of 18,24,000 equity shares of face value of Rs. 10/- each at a price of Rs. 129/- per equity share including a share premium of Rs. 119 per equity share aggregating to Rs. 23.53 crores is herein after referred to as the "net issue". The issue and the net issue will constitute up to 26.52 % and 25.19 %, respectively, of the post issue paid up equity share capital of the company. Price Band: Rs. 129 per equity share of face value Rs. 10/- each. The floor price is 12.9 times of the face value of the equity shares. Bids can be made for a minimum of 2000 equity shares and in multiples of 1000 equity shares thereafter.
*Subject to approvals and market conditions.
Strengths & Risks
Key competitive advantages and factors to consider before investing.
- Experienced Promoters and Management Team.
- Diverse Product Portfolio.
- Commitment to Quality Standards.
- Relationships with Clients and Suppliers.
- Business Processes and Management Framework.
- The company's manufacturing operations are subject to risks, including equipment failures, accidents, and natural disasters, which could disrupt production.
- There are certain discrepancies and non-compliances noticed in some of its corporate records relating to forms filed with the Registrar of Companies, taxation authorities and other public authorities. Any penalty or action taken by any regulatory authorities in future for non- compliance with provisions of all applicable law could impact on the financial position of the Company to that extent.
- The Company is dependents on few numbers of customers for sales. Loss of any of this large customer may affect its revenues and profitability.
- The company has historically derived, and may continue to derives, a significant portion of its supply from top 10 Suppliers.
- The company's Registered Office and Factory is located on premises which are not owned by the company and has been obtained on leased. Disruption of its rights as licensee/ lessee or termination of the agreements with the company's licensors/ lessors may adversely impact its operations and, consequently,the company's business, financial condition and results of operations.